Samsung Biologics has highlighted its contract development and manufacturing organization, or CDMO, capabilities at Biologics Manufacturing Asia 2026 in Singapore, receiving a bioprocessing excellence award during the two-day event.
According to Samsung Biolo
Continue Reading on The Korea Herald
This preview shows approximately 15% of the article. Read the full story on the publisher's website to support quality journalism.